CLINICAL_TRIALS
trial_result
· 2021-03-04
Clinical Trial Update: Nevanimibe HCl for the Treatment of Classic CAH [Phase 2]
Summary
A Phase 2 trial of nevanimibe HCl for congenital adrenal hyperplasia was terminated; results were posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Millendo Therapeutics US, Inc. | Conditions: Congenital Adrenal Hyperplasia | Phase 2 | Status: TERMINATED | Results posted: 2021-03-04